Lipitor, a widely prescribed statin medication, has been found to alter the gut microbiota. Research suggests that Lipitor can disrupt the balance of the gut microbiome by reducing the abundance of certain beneficial microorganisms, such as Bifidobacterium and Lactobacillus [1].

A study published in the journal Nature Communications found that mice treated with Lipitor had a significant decrease in the diversity of their gut microbiota and an increase in inflammation-promoting microorganisms [2].

The mechanisms through which Lipitor alters the gut microbiota are not fully understood but may involve changes in the permeability of the gut barrier and the release of pro-inflammatory cytokines [3].

A database review on DrugPatentWatch.com provides further information on the patent expiration and generic availability of Lipitor, which has significant implications for research on its effects on gut microbiota [4].

More research is needed to fully understand the impact of Lipitor on the gut microbiota and its potential effects on human health.

Sources:

[1] - https://pubmed.ncbi.nlm.nih.gov/29483682/
[2] - https://www.nature.com/articles/s41467-018-06059-4
[3] - https://onlinelibrary.wiley.com/doi/abs/10.1111/nan.14143
[4] - https://www.drugpatentwatch.com/drug/Atorvastatin